Parallax Volatility Advisers
VTVT icon

Parallax Volatility Advisers’s vTv Therapeutics VTVT Stock Holding History

Parallax Volatility Advisers’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-63
Closed -$4K – 3586
2019
Q2 		$4K Hold
63
– – ﹤0.01% 2319
2019
Q1 		$4K Hold
63
– – ﹤0.01% 2594
2018
Q4 		$7K Hold
63
– – ﹤0.01% 2550
2018
Q3 		$2K Hold
63
– – ﹤0.01% 2441
2018
Q2 		$4K Buy
+63
New +$4.65K ﹤0.01% 1859
2018
Q1 		– Sell
-28
Closed -$7K – 4369
2017
Q4 		$7K Buy
+28
New +$6.28K ﹤0.01% 3819

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parallax Volatility Advisers's VTVT Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of vTv Therapeutics (VTVT) in Q3 2019, closing a stake of 63 shares — an estimated $4K sold.

Parallax Volatility Advisers first reported a position in VTVT in Q4 2017 and held it in 6 quarters. The position peaked at $7K in Q4 2018. 19 funds tracked by Wall St. Rank hold VTVT as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining vTv Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 63 vTv Therapeutics shares in Q3 2019, an estimated $4K.
  • Parallax Volatility Advisers first reported a position in vTv Therapeutics in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's vTv Therapeutics position peaked at $7K in Q4 2018.
  • 19 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.